Insider Transactions in Q4 2021 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
8,750
-1.16%
|
-
|
|
Dec 20
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-1.21%
|
$790,000
$79.13 P/Share
|
|
Dec 16
2021
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
15,000
-1.22%
|
-
|
|
Dec 15
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.3%
|
$750,000
$75.2 P/Share
|
|
Dec 10
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-1.15%
|
$710,000
$71.83 P/Share
|
|
Dec 06
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.29%
|
$710,000
$71.33 P/Share
|
|
Dec 02
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.13%
|
$785,325
$75.89 P/Share
|
|
Dec 01
2021
|
Kimberly Blackwell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-16.67%
|
$81,000
$81.84 P/Share
|
|
Dec 01
2021
|
Kimberly Blackwell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.29%
|
$47,000
$47.8 P/Share
|
|
Dec 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.12%
|
$806,267
$77.53 P/Share
|
|
Nov 26
2021
|
Anthony Y Sun President & CEO |
BUY
Bona fide gift
|
Indirect |
125,000
+50.0%
|
-
|
|
Nov 26
2021
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
125,000
-10.0%
|
-
|
|
Nov 22
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-4.35%
|
$750,000
$75.99 P/Share
|
|
Nov 15
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.75%
|
$750,000
$75.82 P/Share
|
|
Nov 10
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-4.17%
|
$780,000
$78.15 P/Share
|
|
Nov 09
2021
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
240,000
+50.0%
|
-
|
|
Nov 09
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
240,000
-24.12%
|
-
|
|
Nov 05
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.73%
|
$820,000
$82.95 P/Share
|
|
Nov 02
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.28%
|
$837,680
$80.27 P/Share
|
|
Nov 01
2021
|
Kimberly Blackwell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-16.67%
|
$80,000
$80.46 P/Share
|
|
Nov 01
2021
|
Kimberly Blackwell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.29%
|
$47,000
$47.8 P/Share
|
|
Nov 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.21%
|
$848,151
$81.97 P/Share
|
|
Oct 25
2021
|
Alexis Pinto Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-26.75%
|
$2,310,000
$77.57 P/Share
|
|
Oct 25
2021
|
Alexis Pinto Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+45.1%
|
$1,020,000
$34.4 P/Share
|
|
Oct 25
2021
|
Kimberly Blackwell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-16.67%
|
$77,000
$77.59 P/Share
|
|
Oct 25
2021
|
Kimberly Blackwell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.29%
|
$47,000
$47.8 P/Share
|
|
Oct 04
2021
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,896
-4.74%
|
$851,136
$66.58 P/Share
|
|
Oct 04
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,799
-0.69%
|
$1,768,734
$66.56 P/Share
|
|
Oct 02
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,080
-6.4%
|
$1,144,360
$67.13 P/Share
|
|
Oct 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-64.03%
|
$555,720
$66.22 P/Share
|
|
Oct 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.54%
|
$660,000
$66.15 P/Share
|